Real life data on nintedanib safety: idiopathic pulmonary fibrosis versus systemic sclerosis-interstitial lung disease and strategies adopted to manage adverse effects

被引:0
作者
Marco Di Battista
Laura Tavanti
Francesco Pistelli
Laura Carrozzi
Mattia Da Rio
Alessandra Rossi
Lorenzo Puccetti
Antonio Tavoni
Chiara Romei
Riccardo Morganti
Alessandra Della Rossa
Marta Mosca
机构
[1] University of Pisa,Rheumatology Unit
[2] University of Siena,Department of Medical Biotechnologies
[3] University of Pisa,Cardiovascular Thoracic Department
[4] University of Pisa,Clinical Immunology and Allergy Unit
[5] University of Pisa,Radiology Unit
[6] University of Pisa,Section of Statistics
来源
Inflammopharmacology | 2023年 / 31卷
关键词
Nintedanib; Systemic sclerosis; Idiopathic pulmonary fibrosis; Safety; Adverse effects; Management strategies;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2445 / 2449
页数:4
相关论文
共 118 条
[11]  
Vanuytsel T(undefined)undefined undefined undefined undefined-undefined
[12]  
Wijsenbeek M(undefined)undefined undefined undefined undefined-undefined
[13]  
Chen CH(undefined)undefined undefined undefined undefined-undefined
[14]  
Lin HC(undefined)undefined undefined undefined undefined-undefined
[15]  
Wang YH(undefined)undefined undefined undefined undefined-undefined
[16]  
Wang CY(undefined)undefined undefined undefined undefined-undefined
[17]  
Lin YS(undefined)undefined undefined undefined undefined-undefined
[18]  
Lai CC(undefined)undefined undefined undefined undefined-undefined
[19]  
Cottin V(undefined)undefined undefined undefined undefined-undefined
[20]  
Martinez FJ(undefined)undefined undefined undefined undefined-undefined